CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Floating Genes is developing innovative tools for early cancer detection using liquid biopsies, specifically targeting digestive cancers. Their patented technology aims to identify circulating tumor DNA in blood samples, potentially saving thousands of lives through earlier diagnosis and personalized treatment.
Floating Genes is a French deeptech startup incorporated in October 2021, developing early cancer detection tools from liquid biopsies.
The company focuses on digestive cancers, and especially colorectal and pancreatic cancer, which is mostly detected in stage 4 and show 4.3 month of median survival.
Floating Genes has developed and patented molecular biology tools to detect very rare circulating tumor DNA (ctDNA) in the blood.
This will eventually allow earlier cancer diagnosis, precise monitor…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
